Pharmeasy

Executive Summary

PharmEasy is India's largest online pharmacy and healthcare platform, offering medicine delivery, teleconsultations, and diagnostic test bookings. The company operates a marketplace model that connects local pharmacies with consumers, supported by a sophisticated supply chain and logistics network. Despite facing valuation markdowns in 2023, the company has pivoted toward debt reduction and profitability, aiming for a sustainable IPO path by 2026. Revenue remains strong at an estimated $800 million, though the company continues to burn cash to maintain market share against conglomerates. Its core strength is its massive user base and brand recognition in a rapidly growing digital healthcare market. This IPO will be a significant test of investor appetite for Indian consumer tech after a period of intense private market correction.